Drug Use Investigation for LAMICTAL

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01376180

Enrollment

3000

Registered

2011-06-20

Start date

2008-12-31

Completion date

2016-08-31

Last updated

2016-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Brief summary

The purpose of this study is to grasp actual status of usage of lamotrigine tablet and to collect information for using lamotrigine tablet effectively and safely as well as to grasp onset status of adverse events in pediatric subjects, geriatric subjects, pregnant women, subjects with poor renal and hepatic functions.

Interventions

DRUGLamotrigine

Administered according to the prescribing information in the locally approved label by the authorities

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Subjects with epilepsy having the following seizure types. * Partial seizures (including secondary generalized seizures) * Tonic-clonic seizures * Generalized seizures of Lennox-Gastaut syndrome

Exclusion criteria

\- None

Design outcomes

Primary

Measure	Time frame
The number of adverse events in Japanese subjects with epilepsy treated with lamotrigine tablet	6 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026